PRIMOLUT N

This brand name is authorized in Australia, Finland, Malta, Netherlands, New Zealand, Nigeria, Singapore, Turkey, UK.

Active ingredients

The drug PRIMOLUT N contains one active pharmaceutical ingredient (API):

1	Norethisterone UNII T18F433X4S - NORETHINDRONE
	Norethisterone has progestational actions similar to those of progesterone, but is a more potent inhibitor of ovulation and has weak oestrogenic and androgenic properties. It is used to treat a number of disorders of the menstrual cycle.
	Read more about Norethisterone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
PRIMOLUT N Tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G03DC02	Norethisterone	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03D Progestogens → G03DC Estren derivatives
Discover more medicines within G03DC02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	2993M
FI	Lääkealan turvallisuus- ja kehittämiskeskus	558718
GB	Medicines & Healthcare Products Regulatory Agency	18635
MT	Medicines Authority	MA639/02501
NG	Registered Drug Product Database	04-5063
Switch country to Nigeria in order to find specific presentations of PRIMOLUT N
NL	Z-Index G-Standaard, PRK	94
NZ	Medicines and Medical Devices Safety Authority	3347
SG	Health Sciences Authority	04403P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699546010066, 8699546015726, 8699546015733